2025年(H1)MNC研发动向全景:技术迭代与结构重塑下的新格局

药智网
Aug 19

导读:2020至2025年间的全球医药市场始终处于动态变革之中。对于跨国药企(MNC)而言,2020至2025年间的全球医药市场始终处于动态变革之中。随着靶向治疗技术的深度演进,医药产业竞争格局逐步定型,全球制药企业若要实现突破性发展,迫切需要依托能引发行业格局重构的 创新药 物机会。这一背景下,中国创新药研发管线近年来持续成为MNC关注的"资源富矿",其创新成果已成为国际药企补充产品矩阵的重要...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10